Insider track record Other Across 27 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Deborah Waterhouse. Director active across 1 company, notably GSK plc. Aggregated, 94 reports have been published. Activity tracked since 9 August 2023. The latest transaction was filed on 9 June 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Declarations 94 total
● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:9614374-6 Ideal exit: 6 Mar 2027 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:03338973-0058-4811-9fe5-7b22157346a2-6 Ideal exit: 6 Mar 2027 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 May 2026 · GSK plc 12 shares @ £18.6558 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:eaad27f1-a91f-4bc4-815a-149202956de0-6 Ideal exit: 6 Feb 2027 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 14 Apr 2026 · GSK plc 824 shares @ £21.67 0.0000% mcap 0.1% of flow GB00BN7SWP63⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-8 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 13 Apr 2026 · GSK plc 12 shares @ £21.7083 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:bae2311e-28b0-4835-a894-0209eedccba9-6 Ideal exit: 8 Jan 2027 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Apr 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:66208821-3d67-43ba-837e-411f45d449f1-13 Ideal exit: 4 Jan 2027 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Apr 2026 · GSK plc 56 shares @ £21.3387 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-7 Ideal exit: 4 Jan 2027 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow GB00BN7SWP63⌘ RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-6 Ideal exit: 5 Dec 2026 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 13 Feb 2026 · GSK plc 162,949 shares 0
GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-22 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 13 Feb 2026 · GSK plc 76,587 shares @ £21.6002 9.7% of flow GB00BN7SWP63⌘ RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-23 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 Feb 2026 · GSK plc 18,543 shares @ £21.50 2.3% of flow GB00BN7SWP63⌘ RNS:6207777f-2477-470b-868f-21f92714189a-8 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 Feb 2026 · GSK plc 136,579 shares @ £21.50 17.3% of flow GB00BN7SWP63⌘ RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-12 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 10 Feb 2026 · GSK plc 12 shares @ £21.7917 0.0% of flow GB00BN7SWP63⌘ RNS:f7024c14-f781-4e48-a904-495085bc7ca2-6 Ideal exit: 7 Nov 2026 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Feb 2026 · GSK plc 44,631 shares 0
GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-14 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Feb 2026 · GSK plc 21,009 shares @ £22.0267 2.7% of flow GB00BN7SWP63⌘ RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-15 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 10 Feb 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:8df504c6-f415-410b-a190-e5ddcfc0debe-2 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 8 Jan 2026 · GSK plc 56 shares @ £18.9432 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-8 Ideal exit: 5 Oct 2026 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 8 Jan 2026 · GSK plc 0
GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-20 Ideal exit: 5 Oct 2026 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Jan 2026 · GSK plc 1,050 shares @ £18.91 0.1% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-32 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 12 Jan 2026 · GSK plc 12 shares @ £18.9325 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-48 Ideal exit: 9 Oct 2026 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Dec 2025 · GSK plc 14 shares @ £18.0779 0.0% of flow GB00BN7SWP63⌘ RNS:58b71e9c-e0b4-4fdd-8b21-5f1119d38ddd-7 Ideal exit: 5 Sept 2026 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 11 Nov 2025 · GSK plc 14 shares @ £18.1421 0.0% of flow GB00BN7SWP63⌘ RNS:802a4789-60c0-4a7f-a34b-b750f1d9f048-7 Ideal exit: 8 Aug 2026 (T+270) ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 29 Oct 2025 · GSK plc 120,000 shares @ £16.8865 17.5% of flow GB00BN7SWP63⌘ RNS:5883105-1 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 10 Oct 2025 · GSK plc 1,199 shares @ £16.40 0.2% of flow GB00BN7SWP63⌘ RNS:5862277-10 ● CEO, ViiV Healthcare and President, Global Health, GSK · Executives · 9 Oct 2025 · GSK plc 62 shares @ £16.3921 0.0% of flow GB00BN7SWP63⌘ RNS:5859068-8 Ideal exit: 6 Jul 2026 (T+270) 25 of 94 declarations
Load more (69 remaining) About Deborah Waterhouse Deborah Waterhouse is a declarant with a total of 94 filings. In her most recent filings, she made a purchase totaling 22690 EUR and sales totaling 8811372 EUR. The first filing date is August 10, 2023, and the last filing date is June 12, 2026. Her filings include significant amounts, such as 3410183.89 EUR on February 21, 2025, and 3368282.72 EUR on February 16, 2026.